High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting (2018)
- Authors:
- USP affiliated authors: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM
- Unidade: FM
- DOI: 10.1080/14397595.2017.1349059
- Subjects: INFECÇÕES OPORTUNISTAS; ARTRITE REUMATOIDE JUVENIL; FATORES DE RISCO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Modern rheumatology
- ISSN: 1439-7595
- Volume/Número/Paginação/Ano: v. 28, n. 2, p. 264-270, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BRUNELLI, Juliana Barbosa et al. High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting. Modern rheumatology, v. 28, n. 2, p. 264-270, 2018Tradução . . Disponível em: https://doi.org/10.1080/14397595.2017.1349059. Acesso em: 13 fev. 2026. -
APA
Brunelli, J. B., Schmidt, A. R., Sallum, A. M. E., Goldenstein-Schainberg, C., Bonfá, E. S. D. de O., Silva, C. A. A. da, & Aikawa, N. E. (2018). High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting. Modern rheumatology, 28( 2), 264-270. doi:10.1080/14397595.2017.1349059 -
NLM
Brunelli JB, Schmidt AR, Sallum AME, Goldenstein-Schainberg C, Bonfá ESD de O, Silva CAA da, Aikawa NE. High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting [Internet]. Modern rheumatology. 2018 ; 28( 2): 264-270.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1080/14397595.2017.1349059 -
Vancouver
Brunelli JB, Schmidt AR, Sallum AME, Goldenstein-Schainberg C, Bonfá ESD de O, Silva CAA da, Aikawa NE. High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting [Internet]. Modern rheumatology. 2018 ; 28( 2): 264-270.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1080/14397595.2017.1349059 - Lupus nephritis-related issues during COVID-19 pandemic quarantine
- Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus
- Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country
- 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity
- Therapeutic guidelines for Latin American Lupus patients methodology
- Long-term evaluation of cardiac function in juvenile idiopathic arthritis under anti-tumor necrosis factor therapy
- Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis
- Ozone decreases sperm quality in systemic lupus erythematosus patients
- Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy
- Human Papilloma Virus and Chlamydia Trachomatis Infections in Rheumatoid Arthitis Under Anti-TNF Therapy
Informações sobre o DOI: 10.1080/14397595.2017.1349059 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas